Clinical application of the I.B.M. cell separator.
Bell Jn , O'Dwyer M , Reen D
Irish Medical Journal 68 ( 17) 407
1975
Outcome in elderly acute myeloid leukaemia.
Murray M , O'Dwyer M , Osman H , Egan E
Irish Medical Journal 101 ( 10) 307
2008
The BH3-mimetic ABT-737 effectively kills acute myeloid leukemia initiating cells.
Denis V. Baev , Janusz Krawczyk , Michael O׳Dwyer , Eva Szegezdi
Leukemia research reports 3 ( 2) 79 -82
12
2014
Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML.
Eimear O’ Reilly , Sukhraj Pal S. Dhami , Denis V. Baev , Csaba Ortutay
Scientific Reports 8 ( 1) 15752 -15752
15
2018
RNA interference for multiple myeloma therapy: targeting signal transduction pathways.
Jianfeng Guo , Sharon L McKenna , Michael E O’Dwyer , Mary R Cahill
Expert Opinion on Therapeutic Targets 20 ( 1) 107 -121
9
2016
Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia
Daniel J DeAngelo , Brian A Jonas , Jane L Liesveld , Dale L Bixby
Blood, The Journal of the American Society of Hematology 139 ( 8) 1135 -1146
20
2022
WORD COUNT
Jo Caers , Laurent Garderet , K Martin Kortüm , Michael E O’Dwyer
Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment
Hannah Egan , Oliver Treacy , Kevin Lynch , Niamh A Leonard
Cell Reports 42 ( 5)
14
2023
GMI-1271, a novel E-selectin antagonist, combined with induction chemotherapy in elderly patients with untreated AML
Daniel J DeAngelo , Brian A Jonas , Dale L Bixby , Pamela S Becker
Platelets 100 ( 28) 22 -51
11
2017
Stromal cell sialylation suppresses T cells in inflammatory tumour microenvironments: A new tumour stromal cell immune checkpoint?
Hannah Egan , Oliver Treacy , Kevin Lynch , Niamh A Leonard
bioRxiv 2021.06. 18.447879 -2021.06. 18.447879
2
2021
GMI-1271, a Potent E-Selectin Antagonist, Combined with Induction Chemotherapy in Elderly Patients with Untreated AML: A Novel, Well-Tolerated Regimen with a High Remission Rate
Daniel J DeAngelo , Brian A Jonas , Dale L Bixby , Pamela S Becker
Platelets 100 ( 28) 22 -51
2017
GMI-1271, a Potent E-Selectin Antagonist, in Combination with Chemotherapy in Relapsed/Refractory AML: A Novel, Well-Tolerated Regimen with a High Remission Rate
Daniel J DeAngelo , Brian A Jonas , Jane L Liesveld , Michael E O’Dwyer
Platelets 100 ( 34) 26 -43
2017
Blood Cancer Network Ireland (BCNI) and National Cancer Registry Ireland (NCRI) collaboration: challenges and utility of an Enhanced Blood Cancer Outcomes Registry (EBCOR) pilot
Seán R Millar , Mohamed Bakri Mohamed , Vitaliy Mykytiv , Rose McMorrow
Irish Journal of Medical Science (1971-) 1 -9
2024
MLN4924, A Novel First in Class Small Molecule Inhibitor of the Nedd8 Activating Enzyme (NAE), Has Potent Activity in Preclinical Models of Acute Myeloid Leukemia.
Ronan T. Swords , Kevin R. Kelly , Peter G. Smith , James J. Gansey
Blood 114 ( 22) 1021 -1021
4
2009
Increased Activity of the S Phase Kinase Cdc7 Is Associated with Poor Outcome in Diffuse Large B Cell Lymphoma (DLBCL).
Janusz Krawczyk , Caoimhe Egan , Michelle Mulvihill , Mark Webber
Blood 114 ( 22) 1914 -1914
4
2009
A Single Centre Analysis of Spectra Optia Stem Cell Collection Data from Multiple Myeloma and Lymphoma Patients, with and without Plerixafor
Joy Buckley , Janusz Krawczyk , Fionnuala Ni Chonchubhair , Nelly Besson
Blood 124 ( 21) 3848 -3848
2014
PHA767491, a Dual Cdc7/CDK9 Inhibitor, with Potential to Target Both Proliferation and Survival in CLL.
Alessandro Natoni , Amjad Hayat , Alessia Montagnoli , Grace Callagy
Blood 114 ( 22) 2366 -2366
2009
Nilotinib 300 Mg Twice Daily Is Effective and Well Tolerated as First Line Treatment of Ph-Positive Chronic Myeloid Leukemia in Chronic Phase: Preliminary Results of the ICORG 0802 Phase 2 Study.
Michael C O'Dwyer , Emma Kent , Michael Parker , Ronan T. Swords
Blood 114 ( 22) 3294 -3294
15
2009
Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.
S V Glavey , A Naba , S Manier , K Clauser
Leukemia 31 ( 11) 2426 -2434
72
2017
E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271
M S Raab , S V Glavey , L Kirkham-McCarthy , S K Kumar
Leukemia 31 ( 12) 2642 -2651
20
2017